Purchase Order 75D30123P16373
- Not listed
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm-fixed price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $143,672.81 contract is for ROCHE REAGENTS AND SUPPLIES with a completion date of December 31, 2018. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies,...
- This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract is for the maintenance of COBAS4800 and COBAS6800 equipment, with a total ceiling value of $130,151.30. The award was made by the Centers for Disease Control and Prevention (CDC) Pittsburgh, a civilian federal agency. The contract is a Delivery Order with a Firm Fixed Price...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The $105,921.20 contract is for sample reagents with a completion date of November 7, 2022. This award was not set aside for any socioeconomic category. Roche Diagnostics has held numerous federal contracts, including...
- This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award, valued at $29,600.00, is for the supply of ROCHE COBAS 5800 REAGENTS under a firm fixed-price purchase order. The contract has an ultimate completion date of June 1, 2024. Roche Diagnostics...
- This firm fixed price purchase order for $77,096.13 was awarded on June 4, 2022 by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for reagents. The contract does not have a set-aside designation. Roche Diagnostics Corp will provide the reagents to the CDC by September 30, 2022. Roche Diagnostics holds multiple General Services Administration Schedule contracts and...
- This is a $86,944 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for a ROCHE SERVICE AGREEMENT with a period of performance through September 2024. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies,...
- This $139,966.72 firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the provision of reagent testing supplies and does not have a set-aside designation. Roche Diagnostics has previously received awards from various federal agencies, including the Department of...
- This is a $84,784.03 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award is not set aside and is for the delivery of ROCHE LAB SUPPLIES. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to various...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer, for the supply of lab supplies. The potential value of the contract is $119,383.20, and the period of performance runs through April 1, 2019. The contract does not have a set-aside designation. Roche Diagnostics is a provider of in vitro diagnostics, reagents, laboratory instruments, and...
- This is a $144,721.10 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for laboratory supplies. The contract has no set-aside designation. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. Roche has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and...
This is a federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the purchase of COBAS PURE C303/E402 clinical chemistry analyzers and associated reagents and supplies. The $460,000.00 firm fixed price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh on April 24, 2023, with an ultimate completion date of December 31, 2023. The contract has no set-aside designation. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and related products and services. Roche has a long history of providing critical care medical equipment, reagents, and testing capabilities to federal agencies like the Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services through prime contracts and subcontracts. This particular award supports the CDC's need for clinical chemistry analyzers and related consumables for its laboratory operations in Castleton, Indiana.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | $0 | 7/23/24 | |
| P00001 | Exercise an Option | $230.0k | 8/21/23 | |
| Not listed | Not listed | $230.0k | 4/24/23 |